These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32766257)

  • 21. The Relationship Between HER-2 Expression Levels and
    Ertürk SA; Hasbek Z; Özer H
    Mol Imaging Radionucl Ther; 2021 Oct; 30(3):150-157. PubMed ID: 34658230
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Satoh K; Sadowski SM; Dieckmann W; Quezado M; Nilubol N; Kebebew E; Patel D
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):714-721. PubMed ID: 27638678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
    Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD
    J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of 18F-FDG PET/CT parameters for reflection of aggressiveness and prediction of prognosis in early-stage cervical cancer.
    Zhang L; Sun H; Du S; Xu W; Xin J; Guo Q
    Nucl Med Commun; 2018 Nov; 39(11):1045-1052. PubMed ID: 30204642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a role for PET/CT parameters to differentiate thyroid cartilage invasion from penetration?
    Kendi AT; Corey A; Magliocca KR; Galt JR; Zhang C; Chen Z; Higgins K; Beitler JJ; Wadsworth JT; El-Deiry MW; Schuster DM; Saba NF; Hudgins PA
    Eur J Radiol; 2016 Feb; 85(2):319-23. PubMed ID: 26781136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of F-18 FDG PET/CT in Intrahepatic Cholangiocarcinoma.
    Lee Y; Yoo IR; Boo SH; Kim H; Park HL; Hyun O J
    Nucl Med Mol Imaging; 2017 Mar; 51(1):69-78. PubMed ID: 28250860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of FDG PET/CT derived parameters in prediction of histopathological finding during the surgery in patients with pancreatic adenocarcinoma.
    Myssayev A; Myssayev A; Ideguchi R; Eguchi S; Adachi T; Sumida Y; Tobinaga S; Uetani M; Kudo T
    PLoS One; 2019; 14(1):e0210178. PubMed ID: 30629646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
    Ding CY; Guo Z; Sun J; Yang WP; Li TR
    Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
    [No Abstract]   [Full Text] [Related]  

  • 29. The prognostic value of
    Grut H; Dueland S; Line PD; Revheim ME
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):218-225. PubMed ID: 29026950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
    Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC
    Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Volume-based parameters on FDG PET may predict the proliferative potential of soft-tissue sarcomas.
    Kitao T; Shiga T; Hirata K; Sekizawa M; Takei T; Yamashiro K; Tamaki N
    Ann Nucl Med; 2019 Jan; 33(1):22-31. PubMed ID: 30196378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from
    Kim YI; Kim YJ; Paeng JC; Cheon GJ; Lee DS; Chung JK; Kang KW
    Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1787-1795. PubMed ID: 28616695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients.
    Kudura K; Dimitriou F; Basler L; Förster R; Mihic-Probst D; Kutzker T; Dummer R; Mangana J; Burger IA; Kreissl MC
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic usefulness of clinical features and pretreatment
    Chen D; Tang M; Lv S; Wang H; Du W; Zhao X; Lin L; Zhu Y; Wang G; Zhu H; Zhao K
    Quant Imaging Med Surg; 2022 May; 12(5):2792-2804. PubMed ID: 35502366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Value of the Volumetric Parameters of Dual-Time-Point
    Okazaki E; Seura H; Hasegawa Y; Okamura T; Fukuda H
    AJR Am J Roentgenol; 2019 Dec; 213(6):1366-1373. PubMed ID: 31509426
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of Various Metabolic Parameters Derived From Baseline 18F-FDG PET/CT as Prognostic Markers in Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy.
    Sharma A; Mohan A; Bhalla AS; Sharma MC; Vishnubhatla S; Das CJ; Pandey AK; Sekhar Bal C; Patel CD; Sharma P; Agarwal KK; Kumar R
    Clin Nucl Med; 2018 Jan; 43(1):e8-e17. PubMed ID: 29112011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Association Between Liver and Tumor [
    Wu X; Bhattarai A; Korkola P; Pertovaara H; Eskola H; Kellokumpu-Lehtinen PL
    Mol Imaging Biol; 2017 Oct; 19(5):787-794. PubMed ID: 28144908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer.
    Crivellaro C; Signorelli M; Guerra L; De Ponti E; Buda A; Dolci C; Pirovano C; Todde S; Fruscio R; Messa C
    Gynecol Oncol; 2012 Oct; 127(1):131-5. PubMed ID: 22772064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of FDG PET/CT in monitoring treatment response in patients with invasive fungal infections.
    Ankrah AO; Span LFR; Klein HC; de Jong PA; Dierckx RAJO; Kwee TC; Sathekge MM; Glaudemans AWJM
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):174-183. PubMed ID: 30343434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment quantitative
    Gencturk M; Ozturk K; Koksel Y; Li F; Cayci Z
    Clin Imaging; 2019; 53():17-24. PubMed ID: 30308429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.